Insider Trading & Ownership of GILEAD SCIENCES, INC.

Location
Foster City, CA
Summary
The estimated value of insider holdings of GILEAD SCIENCES, INC. is at least $894,276,118 dollars as of 01 Dec 2025. GILEAD SCIENCES, INC. is the 10%+ Owner of Arcellx, Inc. and owns shares of Arcellx, Inc. (ACLX) stock worth about $371,444,668. GILEAD SCIENCES, INC. is the 10%+ Owner of Arcus Biosciences, Inc. and owns shares of Arcus Biosciences, Inc. (RCUS) stock worth about $345,672,360. GILEAD SCIENCES, INC. is the 10%+ Owner of ASSEMBLY BIOSCIENCES, INC. and owns shares of ASSEMBLY BIOSCIENCES, INC. (ASMB) stock worth about $100,290,003. GILEAD SCIENCES, INC. is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $36,949,953. GILEAD SCIENCES, INC. is the 10%+ Owner of LEAP THERAPEUTICS, INC. and owns shares of LEAP THERAPEUTICS, INC. (LPTX) stock worth about $15,159,572. GILEAD SCIENCES, INC. is the 10%+ Owner of HOOKIPA Pharma Inc. and owns shares of HOOKIPA Pharma Inc. (HOOK) stock worth about $13,600,612. GILEAD SCIENCES, INC. is the 10%+ Owner of Allovir, Inc. and owns shares of Kalaris Therapeutics, Inc. (KLRS) stock worth about $11,158,950.
Signature
Gilead Sciences, Inc. By: /s/ Andrew D. Dickinson
All Insider Reports
All Insider Reports

Notify me when GILEAD SCIENCES, INC. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of GILEAD SCIENCES, INC.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ACLX Arcellx, Inc. 10%+ Owner $371,444,668 28 Dec 2023
RCUS Arcus Biosciences, Inc. 10%+ Owner $345,672,360 +$14,999,996 +4.5% 18 Feb 2025
ASMB ASSEMBLY BIOSCIENCES, INC. 10%+ Owner $100,290,003 08 Aug 2025
XLO Xilio Therapeutics, Inc. 10%+ Owner $36,949,953 26 Nov 2025
LPTX LEAP THERAPEUTICS, INC. 10%+ Owner $15,159,572 10 Apr 2024
HOOK HOOKIPA Pharma Inc. 10%+ Owner $13,600,612 20 Dec 2023
KLRS Kalaris Therapeutics, Inc. 10%+ Owner $11,158,950 27 Jun 2023
KYTX Kyverna Therapeutics, Inc. 10%+ Owner 12 Feb 2024

Insider Transactions Reported by GILEAD SCIENCES, INC.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.